The pore-forming protein Cry5B elicits the pathogenicity of Bacillus sp. against Caenorhabditis elegans

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Kho, Melanie F ^a   Bellier, Audrey ^a   Balasubramani, Venkatasamy ^a   Hu, Yan ^a   Hsu, Wayne ^a   Nielsen LeRoux, Christina ^d   McGillivray, Shauna M ^b,e   Nizet, Victor ^b,c   Aroian, Raffi V ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UMR1319 MICALIS   (France)

^e TEXAS CHRISTIAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PROTEIN CRY5B; UNCLASSIFIED DRUG; ENDOTOXIN; HEMOLYSIN; INSECTICIDAL CRYSTAL PROTEIN, BACILLUS THURINGIENSIS;

ARTICLE; BACILLUS; BACILLUS ANTHRACIS; BACILLUS MEGATERIUM; BACILLUS SUBTILIS; BACILLUS THURINGIENSIS; BACTERIAL VIRULENCE; CAENORHABDITIS ELEGANS; COCULTURE; CONTROLLED STUDY; INOCULATION; LETHALITY; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

ANIMALS; BACILLUS THURINGIENSIS; BACTERIAL PROTEINS; CAENORHABDITIS ELEGANS; ENDOTOXINS; HEMOLYSIN PROTEINS; VIRULENCE;

EID: 84055216961     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029122     Document Type: Article

References (39)

1. Helgason E, Okstad OA, Caugant DA, Johansen HA, Fouet A, et al. (2000) Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis-one species on the basis of genetic evidence. Appl Environ Microbiol 66: 2627-2630.
2. Kolsto AB, Tourasse NJ, Okstad OA, (2009) What sets Bacillus anthracis apart from other Bacillus species? Annual review of microbiology 63: 451-476.
3. Rasko DA, Altherr MR, Han CS, Ravel J, (2005) Genomics of the Bacillus cereus group of organisms. FEMS microbiology reviews 29: 303-329.
4. Mock M, Fouet A, (2001) Anthrax. Annual review of microbiology 55: 647-671.
5. Drobniewski FA, (1993) Bacillus cereus and related species. Clinical microbiology reviews 6: 324-338.
6. Schnepf E, Crickmore N, Van Rie J, Lereclus D, Baum J, et al. (1998) Bacillus thuringiensis and its pesticidal crystal proteins. Microbiology and molecular biology reviews: MMBR 62: 775-806.
7. Jensen GB, Hansen BM, Eilenberg J, Mahillon J, (2003) The hidden lifestyles of Bacillus cereus and relatives. Environmental microbiology 5: 631-640.
8. Vilas-Boas GT, Peruca AP, Arantes OM, (2007) Biology and taxonomy of Bacillus cereus, Bacillus anthracis, and Bacillus thuringiensis. Can J Microbiol 53: 673-687.
9. Griffitts JS, Aroian RV, (2005) Many roads to resistance: how invertebrates adapt to Bt toxins. BioEssays: news and reviews in molecular, cellular and developmental biology 27: 614-624.
10. de Maagd RA, Bravo A, Crickmore N, (2001) How Bacillus thuringiensis has evolved specific toxins to colonize the insect world. Trends in genetics: TIG 17: 193-199.
11. Alouf JE, (2003) Molecular features of the cytolytic pore-forming bacterial protein toxins. Folia Microbiol (Praha) 48: 5-16.
12. Marroquin LD, Elyassnia D, Griffitts JS, Feitelson JS, Aroian RV, (2000) Bacillus thuringiensis (Bt) toxin susceptibility and isolation of resistance mutants in the nematode Caenorhabditis elegans. Genetics 155: 1693-1699.
13. Kao CY, Los FC, Huffman DL, Wachi S, Kloft N, et al. (2011) Global functional analyses of cellular responses to pore-forming toxins. PLoS pathogens 7: e1001314.
14. Hu Y, Platzer EG, Bellier A, Aroian RV, (2010) Discovery of a highly synergistic anthelmintic combination that shows mutual hypersusceptibility. Proceedings of the National Academy of Sciences of the United States of America 107: 5955-5960.
15. Huffman DL, Abrami L, Sasik R, Corbeil J, van der Goot FG, et al. (2004) Mitogen-activated protein kinase pathways defend against bacterial pore-forming toxins. Proc Natl Acad Sci U S A 101: 10995-11000.
16. Griffitts JS, Haslam SM, Yang T, Garczynski SF, Mulloy B, et al. (2005) Glycolipids as receptors for Bacillus thuringiensis crystal toxin. Science 307: 922-925.
17. Griffitts JS, Huffman DL, Whitacre JL, Barrows BD, Marroquin LD, et al. (2003) Resistance to a bacterial toxin is mediated by removal of a conserved glycosylation pathway required for toxin-host interactions. The Journal of biological chemistry 278: 45594-45602.
18. Regoes RR, Ebert D, Bonhoeffer S, (2002) Dose-dependent infection rates of parasites produce the Allee effect in epidemiology. Proc Biol Sci 269: 271-279.
19. Los FC, Kao CY, Smitham J, McDonald KL, Ha C, et al. (2011) RAB-5- and RAB-11-dependent vesicle-trafficking pathways are required for plasma membrane repair after attack by bacterial pore-forming toxin. Cell host & microbe 9: 147-157.
20. Garsin DA, Sifri CD, Mylonakis E, Qin X, Singh KV, et al. (2001) A simple model host for identifying Gram-positive virulence factors. Proceedings of the National Academy of Sciences of the United States of America 98: 10892-10897.
21. Garsin DA, Villanueva JM, Begun J, Kim DH, Sifri CD, et al. (2003) Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science 300: 1921.
22. Agaisse H, Gominet M, Okstad OA, Kolsto AB, Lereclus D, (1999) PlcR is a pleiotropic regulator of extracellular virulence factor gene expression in Bacillus thuringiensis. Molecular Microbiology 32: 1043-1053.
23. Salamitou S, Ramisse F, Brehelin M, Bourguet D, Gilois N, et al. (2000) The plcR regulon is involved in the opportunistic properties of Bacillus thuringiensis and Bacillus cereus in mice and insects. Microbiology 146 (Pt 11): 2825-2832.
24. Blackburn JK, Curtis A, Hadfield TL, O'Shea B, Mitchell MA, et al. (2010) Confirmation of Bacillus anthracis from flesh-eating flies collected during a West Texas anthrax season. Journal of wildlife diseases 46: 918-922.
25. Borgonie G, Van Driessche R, Leyns F, Arnaut G, De Waele D, et al. (1995) Germination of Bacillus thuringiensis spores in bacteriophagous nematodes (Nematoda: Rhabditida). J Invertebr Pathol 65: 61-67.
26. Schulenburg H, Muller S, (2004) Natural variation in the response of Caenorhabditis elegans towards Bacillus thuringiensis. Parasitology 128: 433-443.
27. Fedhila S, Buisson C, Dussurget O, Serror P, Glomski IJ, et al. (2010) Comparative analysis of the virulence of invertebrate and mammalian pathogenic bacteria in the oral insect infection model Galleria mellonella. Journal of invertebrate pathology 103: 24-29.
28. Schuch R, Pelzek AJ, Kan S, Fischetti VA, (2010) Prevalence of Bacillus anthracis-like organisms and bacteriophages in the intestinal tract of the earthworm Eisenia fetida. Applied and environmental microbiology 76: 2286-2294.
29. Hoffmaster AR, Ravel J, Rasko DA, Chapman GD, Chute MD, et al. (2004) Identification of anthrax toxin genes in a Bacillus cereus associated with an illness resembling inhalation anthrax. Proceedings of the National Academy of Sciences of the United States of America 101: 8449-8454.
30. Rasko DA, Ravel J, Okstad OA, Helgason E, Cer RZ, et al. (2004) The genome sequence of Bacillus cereus ATCC 10987 reveals metabolic adaptations and a large plasmid related to Bacillus anthracis pXO1. Nucleic acids research 32: 977-988.
31. Steichen CT, Kearney JF, Turnbough CL Jr, (2007) Non-uniform assembly of the Bacillus anthracis exosporium and a bottle cap model for spore germination and outgrowth. Molecular Microbiology 64: 359-367.
32. Daou N, Buisson C, Gohar M, Vidic J, Bierne H, et al. (2009) IlsA, a unique surface protein of Bacillus cereus required for iron acquisition from heme, hemoglobin and ferritin. PLoS pathogens 5: e1000675.
33. Sulston J, Hodgkin J, (1988) Methods. In: Wood WB, editors. The Nematode Caenorhabditis elegans Boulder Cold Spring Harbor Laboratory pp. 587-606.
34. Breger J, Fuchs BB, Aperis G, Moy TI, Ausubel FM, et al. (2007) Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog 3: e18.
35. Kim DH, Feinbaum R, Alloing G, Emerson FE, Garsin DA, et al. (2002) A conserved p38 MAP kinase pathway in Caenorhabditis elegans innate immunity. Science 297: 623-626.
36. Moy TI, Ball AR, Anklesaria Z, Casadei G, Lewis K, et al. (2006) Identification of novel antimicrobials using a live-animal infection model. Proc Natl Acad Sci U S A 103: 10414-10419.
37. Shapira M, Hamlin BJ, Rong J, Chen K, Ronen M, et al. (2006) A conserved role for a GATA transcription factor in regulating epithelial innate immune responses. Proc Natl Acad Sci U S A 103: 14086-14091.
38. Tenor JL, McCormick BA, Ausubel FM, Aballay A, (2004) Caenorhabditis elegans-based screen identifies Salmonella virulence factors required for conserved host-pathogen interactions. Curr Biol 14: 1018-1024.
39. Cappello M, Bungiro RD, Harrison LM, Bischof LJ, Griffitts JS, et al. (2006) A purified Bacillus thuringiensis crystal protein with therapeutic activity against the hookworm parasite Ancylostoma ceylanicum. Proc Natl Acad Sci U S A 103: 15154-15159.